MoonLake Immunotherapeutics (MLTX) Interest Expenses (2022 - 2026)

MoonLake Immunotherapeutics' Interest Expenses history runs 3 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• In Q1 2026, Interest Expenses rose 12505.56% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $9.5 million (up 52666.67% YoY), while the FY2025 annual figure was $7.2 million, changed N/A from the prior year.
• Interest Expenses was $2.3 million for Q1 2026 at MoonLake Immunotherapeutics, up from $2.0 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $3.2 million in Q3 2025 to a low of $657.0 in Q1 2022.
• Historically, Interest Expenses has averaged $1.6 million across 3 years, with a median of $2.0 million in 2025.
• Biggest YoY gain for Interest Expenses was 12505.56% in 2026; the steepest drop was 12505.56% in 2026.
• A 3-year view of Interest Expenses shows it stood at $657.0 in 2022, then jumped by 303400.76% to $2.0 million in 2025, then grew by 13.79% to $2.3 million in 2026.
• The last three Interest Expenses figures came in at $2.3 million (Q1 2026), $2.0 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.